weight loss microdosing tirzepatide Women's & Maintenance Microdosing Tirzepatide for Weight Loss:

A new study looking at nearly 877,000 people with type 2 diabetes found that patients who used GLP-1 medications had a higher risk of developing issues with their sense of smell and taste compared to those who took other diabetes medications

2020;137 doi: 10.1016/j.fct.2020.111140

We believe that one of the important mechanisms underlying this effect is likely reduction of inflammation in the fatty tissue around the heart, which we know is an important driver of arrhythmias and other unwanted cardiac outcomes. Bilchick plans to continue investigating these inflammatory mechanisms in collaboration with UVA immunology researcher Coleen McNamara, UVA MRI physicist Frederick Epstein (who developed an MRI method to characterize fatty tissue surrounding the heart), and UVA Director of Cardiac Imaging Amit Patel

Errors in reconstitution are one of the most common reasons for unexpected side effects or underwhelming results